These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 3583507
1. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes. Fogler WE, Fidler IJ. Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507 [Abstract] [Full Text] [Related]
5. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes. Sone S, Mutsuura S, Ogawara M, Tsubura E. J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409 [Abstract] [Full Text] [Related]
6. Muramyl tripeptide phosphatidylethanolamine encapsulated in liposomes stimulates monocyte production of tumor necrosis factor and interleukin-1 in vitro. Maeda M, Knowles RD, Kleinerman ES. Cancer Commun; 1991 Apr; 3(10-11):313-21. PubMed ID: 1722107 [Abstract] [Full Text] [Related]
7. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides. Hoedemakers RM, Vossebeld PJ, Daemen T, Scherphof GL. J Immunother Emphasis Tumor Immunol; 1993 May 04; 13(4):252-60. PubMed ID: 8334109 [Abstract] [Full Text] [Related]
8. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide. Kleinerman ES, Erickson KL, Schroit AJ, Fogler WE, Fidler IJ. Cancer Res; 1983 May 04; 43(5):2010-4. PubMed ID: 6831430 [Abstract] [Full Text] [Related]
9. Systemic activation of tumoricidal properties in mouse macrophages and inhibition of melanoma metastases by the oral administration of MTP-PE, a lipophilic muramyl dipeptide. Fidler IJ, Fogler WE, Brownbill AF, Schumann G. J Immunol; 1987 Jun 15; 138(12):4509-14. PubMed ID: 3584979 [Abstract] [Full Text] [Related]
10. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide. Kleinerman ES. Hematol Oncol Clin North Am; 1995 Aug 15; 9(4):927-38. PubMed ID: 7490249 [Abstract] [Full Text] [Related]
11. Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activating factor gene expression in human monocytes at the transcriptional and post-transcriptional levels. Asano T, Matsushima K, Kleinerman ES. Cancer Immunol Immunother; 1994 Jan 15; 38(1):16-22. PubMed ID: 8299114 [Abstract] [Full Text] [Related]
12. Liposomal muramyl tripeptide up-regulates interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 gene expression in human monocytes. Asano T, McWatters A, An T, Matsushima K, Kleinerman ES. J Pharmacol Exp Ther; 1994 Feb 15; 268(2):1032-9. PubMed ID: 8113959 [Abstract] [Full Text] [Related]